CBD Shark – 1:1 CBD:THC Strain – The Healing Co – 80/20 indica-dominant
Is an 80/20 indica-dominant cannabis strain that offers an equal ratio of THC and CBD, a cannabinoid combination that helps patients treat an array of symptoms like pain, anxiety, and inflammation without the overly intoxicating effects induced by many high-THC strains. This clear-headed hybrid descends from a Shark Shock indica, but as for its second parent, we can only be sure that it was some high-CBD variety. Its aroma is comprised of sweet notes of fruit accented by subtle hints of garlic and herb.
Effects: Relaxed, Sleepy, Focused, Happy, Hungry
Medical: Pain, Fatigue, Inflammation, Stress, Depression
Flavour: Pine, Mint, Earthy
Information provided by Leafly
A ratio of equal parts CBD to THC (1:1) is considered highly effective for pain relief, anxiety, spasticity, fibromyalgia, insomnia, nausea and appetite stimulation. This ratio shows promise in relieving symptoms associated with Multiple Sclerosis and may be able to kill certain cancer cells and inhibit tumor growth. A 1:1 can be a good starting point for many due to the multitude of conditions it may treat with minimal impairment.
People who live with neurodegenerative disorders such as Multiple Sclerosis (MS) may be able to benefit from the advanced anti-inflammatory properties exhibited by both THC and CBD. The Journal of Neuroimmune Pharmacology published an Israeli study in December 2013 focused on MS utilizing a 1:1 ratio with promising results.
Higher THC doses are thought to possibly be key in the treatment of fighting cancer cells and inhibiting tumor growth. CBD has demonstrated promise in inhibiting angiogenesis. When taken together, a study supported the efficacy of a 1:1 treatment regimen for severe cancer related pain.
CBD’s strong anticonvulsant properties have shown promise in controlling seizures, allowing for CBD dominant ratios of 25:1 or even higher to work effectively, particularly in children. However, it is suggested that other cannabinoids are key in maximizing the treatment of seizure related conditions.
CBD dominant options may also be effective for treating mood altering conditions such as schizophrenia due to its antipsychotic effects. A German study published in March 2012 explored this in a double blinded clinical trial.
A study from October 2016 suggests cannabis may be able to assist with the symptoms associated PTSD. PTSD is a very individualized condition, necessitating more studies but higher CBD strains may be a good option for reducing anxiety and stress.